Vicente Felipo Selected Research

Strychnine

9/2020	Blocking glycine receptors reduces neuroinflammation and restores neurotransmission in cerebellum through ADAM17-TNFR1-NF-κβ pathway.
1/2016	Hyperammonemia alters glycinergic neurotransmission and modulation of the glutamate-nitric oxide-cGMP pathway by extracellular glycine in cerebellum in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vicente Felipo Research Topics

Disease

70	Hyperammonemia 04/2024 - 05/2002
53	Hepatic Encephalopathy 01/2024 - 12/2005
33	Neuroinflammatory Diseases 04/2024 - 05/2009
21	Inflammation (Inflammations) 04/2024 - 08/2007
21	Cognitive Dysfunction 01/2024 - 06/2004
19	Liver Failure 09/2015 - 07/2002
15	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 02/2002
13	Liver Diseases (Liver Disease) 04/2024 - 02/2002
11	End Stage Liver Disease 07/2009 - 11/2002
8	Fibrosis (Cirrhosis) 10/2023 - 02/2002
7	Acute Liver Failure (Fulminant Hepatic Failure) 06/2014 - 12/2007
7	Tetanus 01/2010 - 12/2002
6	Ataxia (Dyssynergia) 01/2024 - 09/2015
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 04/2002
5	Hypokinesia (Bradykinesia) 06/2013 - 11/2006
3	Fatty Liver 10/2023 - 10/2018
3	Non-alcoholic Fatty Liver Disease 06/2023 - 10/2018
3	Alzheimer Disease (Alzheimer's Disease) 12/2019 - 01/2003
3	Brain Edema (Cerebral Edema) 06/2014 - 07/2002
3	Memory Disorders (Memory Loss) 11/2008 - 06/2004
2	Fatigue 01/2024 - 11/2023
2	Edema (Dropsy) 02/2011 - 11/2007
2	Ischemia 09/2009 - 04/2002
2	Coma (Comas) 12/2008 - 07/2002

Drug/Important Bio-Agent (IBA)

35	Glutamic Acid (Glutamate)FDA Link 05/2022 - 08/2002
30	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 02/2002
29	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023 - 04/2002
28	AmmoniaIBA 01/2022 - 05/2002
12	gamma-Aminobutyric Acid (GABA)IBA 04/2024 - 04/2009
11	AMPA Receptors (AMPA Receptor)IBA 12/2023 - 04/2007
11	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2002
11	Soluble Guanylyl CyclaseIBA 03/2010 - 02/2002
10	N-Methylaspartate (NMDA)IBA 07/2022 - 01/2005
8	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018 - 12/2002
8	Cyclic GMPIBA 04/2013 - 08/2005
7	Glutamate Receptors (Glutamate Receptor)IBA 12/2023 - 08/2002
7	Interleukin-6 (Interleukin 6)IBA 06/2023 - 08/2007
6	CytokinesIBA 10/2023 - 03/2012
6	Sildenafil Citrate (Viagra)FDA Link 01/2019 - 02/2005
6	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2015 - 02/2004
6	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 06/2013 - 12/2003
5	golexanoloneIBA 01/2024 - 09/2015
5	GABA Plasma Membrane Transport ProteinsIBA 06/2022 - 04/2016
5	EnzymesIBA 10/2018 - 05/2002
5	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2006
5	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2010 - 11/2002
4	NF-kappa B (NF-kB)IBA 04/2024 - 01/2016
4	NeurosteroidsIBA 04/2024 - 04/2009
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2023 - 01/2022
4	sulforaphaneIBA 07/2023 - 02/2016
4	p38 Mitogen-Activated Protein KinasesIBA 07/2023 - 11/2011
4	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2023 - 12/2015
4	Rifaximin (L 105)FDA Link 05/2022 - 01/2019
4	Dinoprostone (PGE2)FDA Link 01/2020 - 08/2010
4	GABA Receptors (GABA Receptor)IBA 01/2020 - 12/2013
4	Glutamine (L-Glutamine)FDA Link 12/2019 - 01/2007
4	Ibuprofen (Motrin)FDA LinkGeneric 01/2019 - 08/2007
4	CorticosteroneIBA 08/2013 - 04/2009
3	Interleukin-17 (Interleukin 17)IBA 04/2024 - 01/2016
3	GABA-A Receptors (GABA(A) Receptor)IBA 04/2024 - 05/2002
3	BicucullineIBA 01/2024 - 01/2019
3	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022 - 01/2020
3	GlutaminaseIBA 01/2022 - 04/2006
3	NitrogenIBA 10/2018 - 12/2005
3	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 12/2013 - 08/2005
3	metabotropic glutamate receptor type 1IBA 06/2013 - 11/2006
3	Atrial Natriuretic Factor (ANF)IBA 02/2013 - 08/2005
3	Interleukin-18 (Interleukin 18)IBA 02/2013 - 03/2009
3	Calcium-Calmodulin-Dependent Protein KinasesIBA 02/2010 - 08/2008
2	Pregnanolone (Allopregnanolone)IBA 04/2024 - 04/2013
2	SteroidsIBA 04/2024 - 11/2022
2	Sphingosine-1-Phosphate ReceptorsIBA 12/2023 - 07/2023
2	StrychnineIBA 09/2020 - 01/2016
2	Glycine Receptors (Glycine Receptor)IBA 09/2020 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2016
2	PregnenoloneIBA 01/2019 - 04/2013
2	Urea (Carbamide)FDA LinkGeneric 10/2018 - 07/2002
2	Peroxynitrous Acid (Peroxynitrite)IBA 01/2018 - 04/2015
2	Infliximab (Remicade)FDA Link 01/2016 - 01/2016
2	Peptides (Polypeptides)IBA 09/2015 - 06/2012
2	Ethanol (Ethyl Alcohol)IBA 02/2015 - 02/2009
2	Dizocilpine Maleate (Dizocilpine)IBA 06/2014 - 11/2007
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2013 - 08/2007
2	GuanosineIBA 07/2012 - 02/2002
2	Neurotransmitter Agents (Neurotransmitter)IBA 06/2012 - 12/2005
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 02/2010 - 12/2009
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 02/2010 - 08/2008
2	Polychlorinated Biphenyls (PCBs)IBA 08/2009 - 01/2008
2	AcetylcholinesteraseIBA 11/2008 - 03/2006
2	CalciumIBA 08/2008 - 05/2002
2	3,4-dihydroxyphenylglycolIBA 10/2007 - 04/2007
2	Nitric Oxide Synthase (NO Synthase)IBA 08/2007 - 07/2007
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2007 - 05/2004
2	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 01/2007 - 12/2005
2	Dihydrotachysterol (AT 10)IBA 12/2005 - 02/2004
1	Interleukin-17 ReceptorsIBA 04/2024

Therapy/Procedure

21	Surgical Portacaval Shunt (Portacaval Anastomosis) 03/2017 - 11/2004
8	Ligation 11/2023 - 12/2005
2	Therapeutics 05/2022 - 01/2022
2	Transplantation 07/2009 - 09/2008